To promote awareness of Melanoma, SKIN teamed up with Melanoma NZ for the opening of the Tauranga Specialist Centre. Minister Simon Bridges raised a toast to the building, and was accompanied by the Mayor Greg Brownless and the Deputy Mayor Kelvin Clout. We discussed that while we are fortunate to have highly qualified specialists in skin cancer in the Bay of Plenty, there is a need to push for an improvement in our Melanoma rates by improving compulsory hat policies in schools and banning sun beds.
We also showcased the building's eco friendly design, with its extensive array of solar panels, solar power emergency back up supply and car charging capabilities.
At the new Tauranga Specialist Centre premises, we have invested in sustainable energy. An extensive array of solar panels has been installed to generate most of the energy requirements of the clinic. It also allows us to function off grid if necessary, with a specially designed solar powered emergency back up supply.
We have also gone one step further and installed an electric car charger so you can power up for free when you attend the clinic!
In early 2017 SKIN moved across the road from the Da Vinci Clinic to new larger premises at The Tauranga Specialist Centre 752 Cameron Rd. We look forward to seeing you soon at our new purpose built facilities, just a block down from the hospital towards town.
World leading Melanoma genetics expert Boris Bastian presented the latest research at the American Academy of Dermatology meeting in Orlando, Florida. There is increasing evidence to support the stepwise progression of benign moles to Melanoma through identifiable transitional steps. The future is to categorise melanomas genetically into groups to allow more accurate prognostic predictions.
Dr Tallon presented information about his latest research into histologic diagnostic features in psoriasis.
Dr Tallon has recently been given the honour of writing for the latest 4th edition of the WHO classification of skin cancers. He is to join a select group of international experts who work to compile the text which is widely used around the world as a reference text.
Recent evidence has given us an additional tool in the fight against skin cancer. Dermatologists from the department of dermatology in the University of Sydney have shown a significant reduction in the rate of skin cancer when individuals at risk of skin cancer were treated with Nicotinamide.
Where is nicotinamide found?
Nicotinamide is a form of Vitamin B3 which is naturally present in small quantities in yeast, lean meats, fish, nuts and legumes. It is also often added to cereals and other foods.
How does nicotinamide work?
The broad clinical effects of nicotinamide may be explained by its role as:
a cellular energy precursor
a modulator of inflammatory cytokines
an inhibitor of the nuclear enzyme poly(adenosine diphosphate-ribose [ADP]) polymerase [PARP], which plays a significant role in DNA repair, maintenance of genomic stability, and cellular response to injury including inflammation and apoptosis (cell death).
How should we use it?
In the study, benefits were gained when individuals were treated with 500g twice daily. No significant side effects were noted. It is important that Nicotinamide is not replaced with Niacin, another form of Vitamin B3, as this tends to cause flushing.
Nicotinamide is available as a supplement which comes in 500mg tablets.
Ask one of the team at SKIN if you have further questions about Nicotinamide and its prevention of skin cancer.
Dr Ben Tallon is convening the Australasian Dermatopathology Society Meeting being held in Auckland's Hilton hotel this weekend. International world leading specialists in dermatopathology have gathered to share their expertise in melanoma and a range of skin disorders.
Great news that the Health Amendment Bill passed its third reading. This means sunbeds are restricted to those over the age of 18. There is a clear link between melanoma and sunbed use, so this bill will prevent unnecessary UV exposure in our youth, and prevent development of melanoma and skin cancers.
Read more here
Dr Tallon has just finished presenting at the American Society for MOHs Surgery meeting in California. The meeting included presentations from the melanoma and dermoscopy experts Dr Riegel and Dr Marghoob. Data was presented on a new 31 gene profiling Castle non invasive test for melanomas which can provide information to predict the melanoma's behaviour.